infecti
diseas
centuri
among
lead
caus
death
chang
fate
entir
civil
black
death
plagu
middl
age
kill
europ
popul
smallpox
twentieth
centuri
respons
million
death
decim
weaken
nativ
popul
america
australia
eighteenth
centuri
prior
final
erad
late
measl
centuri
caus
massiv
destruct
nativ
popul
especi
america
europ
year
declar
erad
us
spite
avail
safe
costeffect
vaccin
continu
circul
variou
part
world
caus
mani
death
global
particularli
among
young
spanish
influenza
epidem
kill
mani
million
peopl
worldwid
consid
devast
epidem
record
world
histori
global
disast
past
decad
least
novel
infecti
agent
affect
human
emerg
zoonot
whose
origin
shown
correl
significantli
environmentalecolog
ie
climat
chang
flood
chang
agricultur
practic
natur
disast
habitat
destruct
socioeconom
ie
increas
popul
densiti
fall
live
standard
declin
infrastructur
human
travel
conflict
social
instabl
kill
wild
anim
food
factor
factor
togeth
natur
evolut
pathogen
constantli
lead
facilit
infect
human
chang
natur
biolog
risk
increas
global
impact
particular
newli
emerg
infect
refer
diseas
discov
human
host
first
time
ie
sever
acut
respiratori
syndrom
coronaviru
sarscov
reemerg
infecti
diseas
defin
infecti
diseas
reappear
usual
pathogen
form
rapidli
increas
incid
new
geograph
locat
appar
control
erad
ie
filovirus
like
ebola
marburg
field
emerg
diseas
explor
strengthen
creation
dedic
emerg
diseas
unit
programm
centr
diseas
control
prevent
cdc
european
centr
diseas
prevent
control
ecdc
institut
monitor
current
infecti
diseas
outbreak
assess
risk
public
health
provid
technic
support
useu
levelrespons
threat
emerg
pathogen
result
deliber
human
action
employ
biolog
weapon
bioweapon
biolog
warfar
bw
destruct
among
socal
cbrn
weapon
biolog
weapon
includ
deadli
pathogen
bacteria
virus
toxin
deliber
releas
order
caus
harm
peopl
anim
plant
agroterror
addit
potenti
catastroph
immedi
impact
agent
could
also
trigger
longterm
disast
caus
region
instabl
challeng
intern
biolog
agent
easili
grown
dissemin
inhal
ingest
skin
absorpt
might
affect
larg
number
peopl
highli
contagi
sarscov
other
might
less
contagi
deadli
affect
ebola
sinc
bioweapon
use
could
resembl
natur
pandem
would
difficult
differenti
natur
occur
infect
result
malici
use
spite
difficulti
evalu
bw
true
frequenc
use
impact
past
due
lack
data
manipulationsecret
polit
author
etc
histor
analysi
shown
biolog
agent
use
sever
occas
ancient
time
twentyfirst
centuri
caus
panic
terror
among
civil
popul
comprehens
histori
biolog
warfar
see
barra
greub
biolog
weapon
convent
bwc
sign
enter
forc
bestow
prohibit
weaponis
biolog
pathogen
particular
bwc
prohibit
possess
biolog
agent
except
prophylact
protect
peac
purpos
ii
develop
technolog
intend
dispers
biolog
agent
offens
militari
purpos
iii
destruct
exist
despit
destruct
potenti
bioweapon
rel
eas
malici
actor
could
obtain
mani
materi
knowhow
requir
build
rel
case
bioterror
sabotag
record
twentieth
twentyfirst
centuri
period
global
total
cbrn
attack
use
potenti
disincent
acquisit
use
bw
might
repres
fact
biolog
agent
indiscrimin
easili
contain
releas
hand
specialist
rais
question
whether
bioterror
myth
realiti
other
consid
bw
common
aspect
human
behaviour
repertoir
knowledg
diffus
rapidli
differ
part
world
globalis
inform
commun
technolog
grow
concern
emerg
biolog
agent
could
easili
use
weapon
nonstat
actor
terrorist
organis
saboteur
lone
actor
futur
moreov
certain
emerg
technolog
scientif
advanc
biotechnolog
ie
nanotechnolog
synthet
biolog
gene
edit
alter
risk
landscap
bioweapon
use
varieti
way
dual
use
concept
malici
use
synthet
edit
pathogen
could
possibl
enabl
hostil
actor
develop
weapon
cheaper
power
easier
use
ie
deadli
virus
polio
ebola
synthes
use
public
databas
avail
technolog
highli
unlik
societi
could
ever
complet
elimin
vulner
biolog
agent
doubt
topic
biolog
warfar
pose
difficult
problem
open
novel
challeng
ethic
domain
sinc
biolog
agent
might
lethal
chemic
weapon
difficult
detect
nuclear
weapon
less
expens
produc
use
common
technolog
avail
biolog
laboratori
measur
intend
enhanc
mitig
diagnost
surveil
etc
adapt
new
therapeut
vaccin
etc
capabl
capac
alongsid
train
educ
improv
abil
societi
combat
regular
infecti
diseas
outbreak
well
counteract
effect
bioterrorist
attack
enhanc
societi
resili
novel
technolog
nanotechnolog
new
detect
technolog
next
gener
sequenc
could
use
cleanup
detect
preserv
health
wellb
first
respond
assist
local
law
enforc
identifi
natur
outbreakattack
kind
biolog
agent
involv
make
respond
easier
reduc
destruct
disrupt
capac
biolog
threat
hand
antimicrobi
vaccin
offer
possibl
mean
protect
toward
sudden
emerg
infecti
diseas
outbreak
natur
intent
import
reli
strateg
reserv
therapeuticsvaccin
known
biothreat
agent
well
toolsplatform
rapid
product
effect
countermeasur
novel
pathogen
gener
pharmaceut
industri
much
involv
vaccin
rare
invest
research
develop
diseas
limit
market
incent
ebola
outbreak
began
vaccin
candid
unavail
stall
pipelin
repeat
outbreak
recent
ebola
zika
forg
global
consensu
current
model
develop
vaccin
sporad
epidem
work
new
system
urgent
need
also
light
pathogen
terrifi
expens
sar
epidem
cost
billion
month
thu
novel
global
approach
need
drive
product
innov
prevent
contain
futur
infecti
diseas
epidem
year
ago
defens
advanc
research
project
agenc
darpa
us
start
support
new
technolog
radic
acceler
manufactur
protein
vaccin
proteinbas
therapeut
realiz
lowcost
plantderiv
vaccin
better
tool
control
mani
infecti
diseas
human
darpa
financ
project
develop
cgmp
facil
plantmad
vaccin
darpa
fund
inovio
pharmaceut
inc
million
develop
multipl
treatment
prevent
approach
ebola
dnabas
vaccin
ebola
therapeut
dnabas
monoclon
antibodi
product
convent
monoclon
antibodi
treat
ebola
recent
biolog
technolog
offic
bto
darpa
sponsor
pandem
prevent
platform
program
whose
goal
achiev
integr
capabl
deliv
pandem
prevent
countermeasur
patient
within
day
outbreak
chang
outbreak
respons
enabl
rapid
discoveri
character
product
test
efficaci
medic
countermeasur
ie
gener
viru
stock
includ
viral
unknown
rapid
evolut
antibodi
candid
geneencod
antibodi
deliveri
method
anoth
initi
repres
global
health
secur
ghsa
launch
februari
grow
partnership
nation
intern
organ
nongovernment
stakehold
pursu
multilater
multisector
approach
strengthen
global
capac
nation
capac
prevent
detect
respond
infecti
diseas
threat
whether
natur
occur
deliber
accident
idea
capac
establish
would
mitig
devast
effect
threat
pose
highli
pathogen
infecti
diseas
bioterror
event
rapidli
detect
transpar
report
outbreak
occur
employ
interconnect
global
network
respond
effect
limit
spread
infecti
diseas
outbreak
human
anim
mitig
human
suffer
loss
human
life
reduc
econom
impact
besid
socal
one
health
initi
strategi
control
diseas
across
speci
recent
januari
coalit
epidem
prepared
innov
cepi
launch
world
econom
forum
partnership
public
privat
philanthrop
civil
organ
acceler
safe
afford
vaccin
develop
emerg
infecti
diseas
particularli
diseas
lack
market
incent
readi
pandem
defenc
peacetim
base
memorandum
understand
world
health
organ
establish
partnership
bill
melinda
gate
foundat
govern
like
india
germani
japan
norway
industri
partner
privat
funder
ie
wellcom
trust
academ
institut
civil
societi
organis
among
other
accord
r
blueprint
action
prevent
epidem
indic
prioriti
pathogen
develop
medic
countermeasur
urgent
need
base
specif
criteria
risk
outbreak
occur
transmiss
pathogen
burden
diseas
feasibl
vaccin
develop
current
pipelin
candid
first
step
three
diseas
select
lassa
fever
nipah
viru
middl
east
respiratori
syndrom
coronaviru
merscov
move
new
vaccin
preclin
proof
principl
studi
human
howev
sinc
alway
unknown
select
pathogen
possibl
predict
cepi
aim
also
support
develop
rapid
adapt
vaccin
technolog
platform
antigen
new
pathogen
substitut
ad
exist
vaccin
sever
acut
respiratori
syndrom
sar
emerg
spread
countri
contin
lead
infect
patient
fatal
rate
aetiolog
agent
syndrom
rapidli
identifi
coronaviru
sarscov
cross
speci
barrier
infect
human
show
high
morbid
mortal
rate
end
sar
outbreak
declar
juli
howev
sever
local
outbreak
subsequ
report
china
consequ
accident
laboratori
contamin
infect
contact
anim
infect
sarscov
strain
significantli
differ
predomin
outbreak
high
transmiss
high
lethal
signific
impact
public
health
system
sarscov
defin
class
c
biolog
weapon
center
diseas
control
prevent
current
approv
antivir
treatment
sarscov
sinc
sar
epidem
may
recur
time
futur
includ
r
blueprint
action
prevent
epidem
list
multipl
therapeut
approach
sarscov
merscov
current
develop
recent
exampl
effort
repres
nucleotid
prodrug
current
clinic
develop
treatment
ebola
viru
diseas
show
inhibit
sarscov
merscov
replic
multipl
vitro
system
mous
model
sarscov
pathogenesi
anoth
import
key
prevent
control
futur
outbreak
sar
develop
novel
rapid
specif
diagnost
method
addit
alreadi
suspect
patient
correctli
triag
isol
sarscov
four
major
viral
structur
compon
spike
envelop
e
membran
nucleocapsid
n
protein
nonstructur
protein
structur
n
protein
abund
protein
respect
viru
core
viral
envelop
n
protein
express
earli
stage
infect
trigger
earli
power
antibodi
respons
host
thu
consid
best
diagnost
target
furthermor
sinc
n
protein
abl
induc
longterm
cellmedi
immun
respons
anim
model
repres
potenti
vaccin
candid
product
recombin
n
protein
achiev
varieti
heterolog
express
system
eukaryot
platform
insect
cell
yeast
allow
effici
specif
diagnost
test
membran
glycoprotein
function
involv
assembl
bud
virion
cell
protein
contain
cell
epitop
avail
recombin
protein
combin
recombin
viral
protein
might
overcom
concern
sensit
specif
n
proteinbas
assay
thu
provid
high
qualiti
reagent
detect
antibodi
infect
human
host
recent
demonstr
plant
transient
express
system
use
produc
sarscov
n
antigen
n
fulllength
gene
deriv
frankfurt
isol
human
sarscov
insert
differ
plant
express
vector
n
protein
express
nicotiana
benthamiana
plant
use
potato
viru
x
pvx
mediat
infect
protein
obtain
system
leav
infect
plant
differ
n
protein
produc
bacteria
plantproduc
n
protein
display
proteolysi
demonstr
suitabl
plant
platform
product
recombin
sarscov
antigen
fig
addit
demonstr
crude
extract
contain
n
protein
purifi
plantproduc
n
protein
specif
recogn
immunoblot
sera
deriv
chines
sar
convalesc
patient
outbreak
patient
affect
unrel
respiratori
diseas
studi
repres
first
demonstr
plantderiv
n
protein
abl
reveal
direct
serolog
human
nspecif
antibodi
present
sera
sar
patient
thu
provid
adequ
instrument
develop
rapid
lowcost
immunebas
diagnost
assay
use
altern
associ
molecular
diagnosi
protein
demonstr
wild
type
protein
toxic
express
bacteria
mutat
form
obtain
system
accumul
inclus
bodi
contrari
demonstr
plant
allow
express
fulllength
origin
protein
particular
obtain
solubl
protein
n
benthamiana
plant
use
agrobacterium
tumefaciensmedi
infect
reduc
electrophoret
mobil
observ
plantderiv
protein
compar
produc
bacteria
suggest
presenc
glycosyl
nativ
protein
nglycosyl
fourth
residu
provid
eukaryot
system
result
provid
proof
principl
use
plant
robust
rapid
flexibl
product
system
protein
reagent
suitabl
face
potenti
recur
sarscov
outbreak
sever
year
ago
demonstr
therapeut
anticanc
dna
vaccin
potenti
use
plant
immunemodul
sequenc
drive
idea
plant
protein
involv
plant
defenc
respons
due
similar
mammalian
plant
immun
mechan
might
effect
tumour
human
immun
modul
innat
immun
function
turn
possibl
true
induc
tumourspecif
antigen
tsa
link
adapt
cellmedi
immun
crucial
cancer
resolut
recent
develop
genet
vaccin
plant
protein
signal
sequenc
ss
fuse
ntermin
portion
crucial
viral
antigen
deriv
human
papillomaviru
type
hpv
syntheticfus
gene
deriv
protein
mammalian
cell
transfect
studi
transient
express
intracellular
fate
protein
encod
novel
dna
construct
case
construct
protein
found
cultur
medium
transfect
cell
wherea
without
ss
present
cell
lysat
demonstr
abil
plant
signal
sequenc
modul
sort
heterolog
protein
mammalian
cell
plant
ss
found
modifi
process
also
construct
ie
gene
fuse
coat
protein
potato
viru
x
even
though
secret
observ
cultur
medium
protein
detect
mostli
cytoplasm
transfect
cell
immunolog
effect
ss
provid
dna
vaccin
studi
anim
model
hpv
mice
primeboost
schedul
impli
use
electropor
ep
intramuscular
immun
demonstr
plant
signal
sequenc
enhanc
humor
respons
dnabas
vaccin
electropor
ep
inde
appear
promis
approach
improv
immunogen
dna
vaccin
abil
increas
cellular
permeabl
result
high
level
protein
express
improv
immun
respons
recent
clinic
trial
shown
vaccin
schedul
compris
prime
dna
plasmid
time
zero
boost
dna
interv
intraderm
id
ep
immun
result
induct
strong
humor
immun
respons
confirm
id
ep
effici
intramuscular
im
vaccin
particular
plasmid
abl
produc
highest
titer
igg
ep
immun
protocol
determin
also
longstand
humor
immun
respons
persist
least
month
util
mous
model
preliminari
experi
seem
indic
neutral
natur
antibodi
best
knowledg
first
demonstr
signal
sequenc
plant
protein
may
exert
biolog
activ
mammalian
cell
enhanc
immunogen
antigen
interest
approach
might
work
also
antigen
even
rel
larg
glycoprotein
differ
pathogen
open
new
perspect
design
dna
vaccin
especi
counteract
infect
fast
effect
humor
respons
need
genet
vaccin
easili
produc
industri
scale
accord
gmp
provid
effect
safe
vaccin
involv
product
chemocytokin
might
induc
secondari
respons
anim
antigen
could
caus
cross
autoimmun
respons
order
avoid
devast
loss
life
possibl
viral
outbreak
next
ebola
zika
avian
flu
mer
biolog
warfar
bw
attack
whose
epidemiolog
associ
sudden
unforeseen
contagi
burst
necessari
reli
small
stockpil
readi
next
outbreak
begin
time
fundament
invest
technic
platform
abl
cut
time
tailor
eventu
vaccin
candid
effect
epidem
word
outbreak
happen
vaccin
readi
weeksmonth
fieldtest
massmanufactur
two
platform
introduc
plant
bioreactor
product
biopharmaceut
plant
molecular
farm
improv
genet
vaccin
endow
plant
sequenc
immunemodul
activ
repres
two
promis
complementari
approach
rapid
afford
product
countermeasur
diagnost
vaccin
candid
emerg
reemerg
bioterrorismrel
infect
